PE-Linked Polyclonal Antibody to Osteopontin (OPN)
Cat# MBS2118467-1mL
Size : 1mL
Brand : MyBiosource
Osteopontin (OPN) Antibody – Rabbit Polyclonal
For Research Use Only. Not for use in diagnostic procedures. Special Promotion Catalog #: MBS2118467SPECIAL PROMOTION: Get FREE Starbucks gift card (Maximum 5 gift cards/product). Gift card(s) will be included with shipment
MBS2118467 is an antibody targeting OPN. Also known as PE-Linked Polyclonal Antibody to Osteopontin (OPN). Reactive in Bovine. Host: Rabbit. More details
Product Overview
Online Datasheet in PDFProduct Name
Osteopontin (OPN), Polyclonal Antibody
Full Product Name
PE-Linked Polyclonal Antibody to Osteopontin (OPN)
Product Gene Name
anti-OPN antibody
Product Synonym Names
SPP1; BNSP; BSPI; ETA1; Secreted Phosphoprotein 1; Bone Sialoprotein I; Early T-Lymphocyte Activation 1; Nephropontin; Urinary stone protein; Uropontin
Clonality
Polyclonal
Host
Rabbit
Species Reactivity
Bovine
Form/Format
Liquid; PBS, pH7.4, containing 0.02% NaN3, 50% glycerol.
Purity/Purification
Antigen-specific affinity chromatography followed by Protein A affinity chromatography
Concentration
>=100ug/ml (lot specific)
Specificity
The antibody is a rabbit polyclonal antibody raised against OPN. It has been selected for its ability to recognize OPN in immunohistochemical staining and western blotting.
Preparation and Storage
Store at 4 degree C for frequent use. Aliquot and store at -20 degree C for 12 months.
Avoid repeated freeze/thaw cycles.
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37 degree C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.
Avoid repeated freeze/thaw cycles.
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37 degree C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.
Matching Pairs
Unconjugated Antibody: OPN (MBS2112037)
PE Conjugated Antibody: OPN (MBS2118467)
PE Conjugated Antibody: OPN (MBS2118467)
Molecular Weight
30,904 Da
Supply Chain Verification
Manufactured in a lab with traceable raw materials. Bulk orders can typically be prepared to the customer’s specifications, please inquire.
Cross Reactivity
Cattle
Conjugation
PE
Product Categories/Family for anti-OPN antibody
Tumor Immunity; Bone Metabolism
ISO Certification
Manufactured in an ISO 9001:2015 and ISO 13485:2016 Certified Laboratory.
Applications Tested/Suitable for anti-OPN antibody
Western Blot (WB), Immunohistochemistry (IHC), Immunocytochemistry (ICC), Immunoprecipitation (IP)
Other Notes
Small volumes of anti-OPN antibody vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Additional Details
NCBI/Uniprot data below describe general gene information for OPN. It may not necessarily be applicable to this product.
NCBI Official Full Name
osteopontin
NCBI Official Symbol
SPP1
NCBI Official Synonym Symbols
OPN; OST
UniProt Protein Name
Osteopontin
UniProt Synonym Protein Names
Bone sialoprotein 1; Secreted phosphoprotein 1; SPP-1
UniProt Gene Name
SPP1
UniProt Synonym Gene Names
OPN; SPP-1
NCBI Protein Information
osteopontin
UniProt Comments for OPN
Binds tightly to hydroxyapatite. Appears to form an integral part of the mineralized matrix. Probably important to cell-matrix interaction.Acts as a cytokine involved in enhancing production of interferon-gamma and interleukin-12 and reducing production of interleukin-10 and is essential in the pathway that leads to type I immunity.
Show more Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
Product Note
Select online data sheet information is drawn from bioinformatics databases, occasionally resulting in ambiguous or non-relevant product information. It is the responsibility of the customer to review, verify, and evaluate the information to make sure it matches their requirements before purchasing the kit. Our ELISA Kit assays are dynamic research tools and sometimes they may be updated and improved. If the format of this assay is important to you then please request the current manual or contact our technical support team with a presales inquiry before placing an order. We will confirm the current details of the assay. We cannot guarantee the sample manual posted online is the most current manual, it is intended to serve as an example only. Please refer to the instructions For Use provided with the assay kit for precise details.
Product PubMed Publications
Products associated with anti-OPN antibody
| Reference Product | PubMed Publications |
|---|---|
| CD44 antibody | >136 publications with OPN and CD44 |
| THBS1 antibody | >14 publications with OPN and THBS1 |
| MMP7 antibody | >11 publications with OPN and MMP7 |
| ITGA4 antibody | >10 publications with OPN and ITGA4 |
| ITGB3 antibody | >5 publications with OPN and ITGB3 |
| ITGA5 antibody | >5 publications with OPN and ITGA5 |
| ITGAV antibody | >3 publications with OPN and ITGAV |
| ITGB1 antibody | >3 publications with OPN and ITGB1 |
| ITGA8 antibody | >2 publications with OPN and ITGA8 |
Pathways associated with anti-OPN antibody
| Products by Pathway | Pathway Diagram |
|---|---|
| BDNF Signaling Pathway antibodies | BDNF Signaling Pathway Diagram |
| Degradation Of The Extracellular Matrix Pathway antibodies | Degradation Of The Extracellular Matrix Pathway Diagram |
| ECM-receptor Interaction Pathway antibodies | ECM-receptor Interaction Pathway Diagram |
| ECM-receptor Interaction Pathway antibodies | ECM-receptor Interaction Pathway Diagram |
| Endochondral Ossification Pathway antibodies | Endochondral Ossification Pathway Diagram |
| Extracellular Matrix Organization Pathway antibodies | Extracellular Matrix Organization Pathway Diagram |
| Focal Adhesion Pathway antibodies | Focal Adhesion Pathway Diagram |
| Focal Adhesion Pathway antibodies | Focal Adhesion Pathway Diagram |
| Focal Adhesion Pathway antibodies | Focal Adhesion Pathway Diagram |
| Integrin Cell Surface Interactions Pathway antibodies | Integrin Cell Surface Interactions Pathway Diagram |
Diseases associated with anti-OPN antibody
| Disease Name | Pubmed Publications |
|---|---|
| Disease Models, Animal Antibodies | >286 publications with OPN and Disease Models, Animal |
| Inflammation Antibodies | >282 publications with OPN and Inflammation |
| Kidney Diseases Antibodies | >241 publications with OPN and Kidney Diseases |
| Fibrosis Antibodies | >171 publications with OPN and Fibrosis |
| Neoplasm Metastasis Antibodies | >143 publications with OPN and Neoplasm Metastasis |
| Necrosis Antibodies | >138 publications with OPN and Necrosis |
| Adenocarcinoma Antibodies | >120 publications with OPN and Adenocarcinoma |
| Calcinosis Antibodies | >119 publications with OPN and Calcinosis |
| Heart Diseases Antibodies | >111 publications with OPN and Heart Diseases |
| Neoplasms, Experimental Antibodies | >86 publications with OPN and Neoplasms, Experimental |
Organs/Tissues associated with anti-OPN antibody
| Organ/Tissue Name | Pubmed Publications |
|---|---|
| Blood Antibodies | >578 publications with OPN and Blood |
| Kidney Antibodies | >378 publications with OPN and Kidney |
| Muscle Antibodies | >301 publications with OPN and Muscle |
| Liver Antibodies | >146 publications with OPN and Liver |
| Cartilage Antibodies | >125 publications with OPN and Cartilage |
| Lung Antibodies | >118 publications with OPN and Lung |
| Brain Antibodies | >106 publications with OPN and Brain |
| Skin Antibodies | >91 publications with OPN and Skin |
| Adipose Tissue Antibodies | >40 publications with OPN and Adipose Tissue |
| Intestine Antibodies | >30 publications with OPN and Intestine |


